Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen...
9 KB (548 words) - 22:50, 16 August 2024
Administration (FDA) approved a biologic license application (BLA) for alglucosidase alfa, rhGAA (Myozyme), the first treatment for patients with Pompe disease...
36 KB (4,291 words) - 10:01, 3 August 2024
drug alglucosidase alfa became the first released treatment for Pompe disease and acts as an analog to α-glucosidase. Further studies of alglucosidase alfa...
15 KB (1,751 words) - 14:31, 1 July 2024
Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe...
16 KB (1,224 words) - 05:11, 16 July 2024
filler), for facial wrinkles. Lumizyme (Alglucosidase alfa), for Pompe disease. Myozyme (Alglucosidase alfa), for Pompe disease. Sculptra (Polylactic...
91 KB (8,778 words) - 06:05, 10 August 2024
Sebelipase alfa IV MPS I Laronidase IV MPS II Idursulfase IV MPS IVA Elosulfase alfa IV MPS VI Galsulfase IV Pompe disease Alglucosidase alfa (160L bioreactor)...
13 KB (1,367 words) - 23:00, 31 December 2023
Imiglucerase A16AB03 Agalsidase alfa A16AB04 Agalsidase beta A16AB05 Laronidase A16AB06 Sacrosidase A16AB07 Alglucosidase alfa A16AB08 Galsulfase A16AB09 Idursulfase...
3 KB (358 words) - 02:46, 18 December 2023
(December 2021). "Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an...
12 KB (908 words) - 12:29, 14 June 2024
algeldrate (INN) algenpantucel-L (USAN) algestone (INN) alglucerase (INN) alglucosidase alfa (USAN) alibendol (INN) alicaforsen (INN, USAN) aliconazole (INN) alifedrine...
12 KB (580 words) - 06:59, 25 December 2023
approval of the first enzyme replacement therapy for Pompe's disease - Alglucosidase alfa (Myozyme or Lumizyme, Genzyme Inc) in 2006. William Canfield's work...
4 KB (424 words) - 07:32, 11 May 2023
Foundation Website 2010 NEJM, 2010, 362:1396–1406 A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease Suberoylanilide hydroxamic acid (SAHA;...
9 KB (1,133 words) - 22:04, 6 September 2023